General information about company

Scrip code539378
NSE Symbol
MSEI Symbol
ISININE848R01018
Name of the entitySONI MEDICARE LIMITED
Date of start of financial year01-04-2018
Date of end of financial year31-03-2019
Reporting QuarterYearly
Date of Report31-03-2019
Risk management committeeNot Applicable



Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatoryTextual Information(1)
Wether the listed entity has a Regular ChairpersonYes
SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directorsDate of appointment in the current term Date of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 25(1) of Listing Regulations)Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Notes for not providing PANNotes for not providing DIN
1MrBIMAL ROY SONIAFPPS1588H00716246Executive DirectorChairpersonMD26-09-2017100
2MrMAHAVIR PRASAD YADAVAARPY8838K05249381Non-Executive - Independent DirectorNot Applicable30-09-201560121
3MrSUMER CHAND JAINACUPJ8426H00254274Non-Executive - Independent DirectorNot Applicable30-09-201560110
4MrsANJU SONIAFPPS1706M00716193Non-Executive - Non Independent DirectorNot Applicable02-08-1988121



Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory

SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directorsDate of appointment in the current term Date of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 25(1) of Listing Regulations)Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Notes for not providing PANNotes for not providing DIN
5MrsMAMTA SHARMAAHXPS6519E07060149Non-Executive - Independent DirectorNot Applicable30-09-201560120



Text Block

Textual Information(1)

Mr. Bimal Roy Soni originally appointed as director on dated 02-08-1988 and re-designated as Managing Director on dated 26-09-2017

Mr. MAHAVIR PRASAD YADAV is Chairperson of Audit Committee and Member of Nomination and Remuneration committee and Stakeholder Committee

Mr. SUMER CHAND JAIN is Chairman of Nomination and Remuneration committee and Member of Stakeholder Committee

Mrs. ANJU SONI is member of the Audit Committee and Nomination and Remuneration Committee and Chairperson of Stakeholders Committee

Mrs. MAMTA SHARMA is member of Audit Committee, Nomination and Remuneration committee and Stakeholder Committee




Annexure 1

II. Composition of Committees

Disclosure of notes on composition of committees explanatoryTextual Information(1)

Annexure 1 Text Block

Textual Information(1)

Audit Committee

 

Mr. M.P Yadav

Chairman

 

Mrs. Mamta Sharma

Member

 

Mrs. Anju Soni

Member

Nomination and Remuneration Committee

 

Mr. Sumer Chand Jain

Chairman

 

Mr. M.P Yadav

Member

 

Mrs. Mamta Sharma

Member

 

Mrs. Anju Soni

Member

Stakeholders Relationship Committee

 

Mrs. Anju Soni

Chairperson

 

Mr. M.P Yadav

Member

 

Mr. Sumer Chand Jain

Member

 

Mrs. Mamta Sharma

Member



Audit Committee Details

Whether the Audit Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
105249381MAHAVIR PRASAD YADAVNon-Executive - Independent DirectorChairperson06-01-2015
200716193ANJU SONINon-Executive - Non Independent DirectorMember30-09-2015
307060149MAMTA SHARMANon-Executive - Independent DirectorMember06-01-2015


Nomination and remuneration committee

Whether the Nomination and remuneration committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
100254274SUMER CHAND JAINNon-Executive - Independent DirectorChairperson06-01-2015
205249381MAHAVIR PRASAD YADAVNon-Executive - Independent DirectorMember06-01-2015
307060149MAMTA SHARMANon-Executive - Independent DirectorMember06-01-2015
400716193ANJU SONINon-Executive - Non Independent DirectorMember30-09-2015


Stakeholders Relationship Committee

Whether the Stakeholders Relationship Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
100716193ANJU SONINon-Executive - Non Independent DirectorChairperson30-09-2015
200254274SUMER CHAND JAINNon-Executive - Independent DirectorMember06-01-2015
305249381MAHAVIR PRASAD YADAVNon-Executive - Independent DirectorMember06-01-2015
407060149MAMTA SHARMANon-Executive - Independent DirectorMember30-09-2015


Risk Management Committee

Whether the Risk Management Committee has a Regular Chairperson
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Corporate Social Responsibility Committee

Whether the Corporate Social Responsibility Committee has a Regular ChairpersonNo
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Other Committee

SrDIN NumberName of Committee membersName of other committeeCategory 1 of directorsCategory 2 of directorsRemarks

Annexure 1

Annexure 1

III. Meeting of Board of Directors

Disclosure of notes on meeting of board of directors explanatoryTextual Information(1)
SrDate(s) of meeting (if any) in the previous quarterDate(s) of meeting (if any) in the current quarterMaximum gap between any two consecutive (in number of days)Notes for not providing Date
113-11-2018
214-02-201992



Text Block

Textual Information(1)

 

 The Board at its meeting on 14th February, 2019, has considered the below mentioned business:

a)     Confirm and approve the minutes of the previous meeting of board of directors held on

13th November, 2018.

 

b)     Confirm and approve the minutes of the previous meeting of Audit Committee held on 13th November, 2018.

 

c)      Consider the proceedings of the Audit Committee held on 14th February, 2019.

 

d)     Approve the Standalone Unaudited financial results for the quarter ended 31st December, 2018 along with Limited Review Report of the auditors.

 

e)     To take on record the certified share capital audit from PCS for the quarter ended 31st December, 2018.

 

f)       To take note Corporate Governance Report for the quarter ended 31st December, 2018.

 

g)     To take note of the Shareholding Pattern as per Regulation 31 for the quarter ended 31st  December, 2018.

 

h)     In all the above meeting quorum was duly met.

 




Annexure 1

IV. Meeting of Committees

Disclosure of notes on meeting of committees explanatory Textual Information(1)
SrName of CommitteeDate(s) of meeting of the committee in the relevant quarterWhether requirement of Quorum met (Yes/No)Requirement of Quorum metDate(s) of meeting of the committee in the previous quarterMaximum gap between any two consecutive meetings (in number of days)Name of other committeeReson for not providing date
1Audit Committee14-02-2019Yes313-11-201892



Text Block

Textual Information(1)

1. Audit Committee meeting was held on 14-02-2019

To approve the Standalone Unaudited financial results for the quarter ended & half year ended 31st December, 2018  along with the limited review report of the auditors.




Annexure 1

V. Related Party Transactions

SrSubjectCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
1Whether prior approval of audit committee obtainedYes
2Whether shareholder approval obtained for material RPTNA
3Whether details of RPT entered into pursuant to omnibus approval have been reviewed by Audit CommitteeYes
Disclosure of notes on related party transactions Textual Information(1)
Disclosure of notes of material transaction with related partyTextual Information(2)


Text Block

Textual Information(1)

SONI MEDICARE LIMITED

DETAILS OF RELATED PARTY TRANSACTION DURING THE QUARTER JANUARY 19 TO MARCH 19                                 

S.NO.

NAME OF PERSON / PARTY

RELATION

TRASACTION

 AMOUNT

1

DR. BIMAL ROY SONI

MANAGING DIRECTOR

CONSULTANCY

                   120,000.00

LEASE RENT - BUILDING

                   123,000.00

2

DR. ANJU SONI

DIRECTOR

CONSULTANCY

                    525,000.00

3

MR. NAMIT SONI

SON OF DIRECTOR

SALARY

300,000.00

4

MRS. NEHA SONI

DAUGHTER IN LAW OF DIRECTOR

SALARY

180,000.00

5

M/S S S PHARMACY

PARTNERSHIP FIRM IN WHICH DIRECTORS ARE PARTNER

MEDICINE AND MEDICAL CONSUMABLES PURCHASED

                    336,532.00

 

 

Textual Information(2)

SONI MEDICARE LIMITED

DETAILS OF RELATED PARTY TRANSACTION DURING THE QUARTER JANUARY 19 TO MARCH 19                                 

S.NO.

NAME OF PERSON / PARTY

RELATION

TRASACTION

 AMOUNT

1

DR. BIMAL ROY SONI

MANAGING DIRECTOR

CONSULTANCY

                   120,000.00

LEASE RENT - BUILDING

                   123,000.00

2

DR. ANJU SONI

DIRECTOR

CONSULTANCY

                    525,000.00

3

MR. NAMIT SONI

SON OF DIRECTOR

SALARY

300,000.00

4

MRS. NEHA SONI

DAUGHTER IN LAW OF DIRECTOR

SALARY

180,000.00

5

M/S S S PHARMACY

PARTNERSHIP FIRM IN WHICH DIRECTORS ARE PARTNER

MEDICINE AND MEDICAL CONSUMABLES PURCHASED

                    336,532.00

 

 




Annexure 1

VI. Affirmations

SrSubjectCompliance status (Yes/No)
1The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015Yes
2The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit CommitteeYes
3The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committeeYes
4The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committeeYes
5The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 100 listed entities)NA
6The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
7The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
8This report and/or the report submitted in the previous quarter has been placed before Board of Directors.Yes

Annexure 1

SrSubjectCompliance status
1Name of signatoryPOOJA SHARMA
2DesignationCompany Secretary and Compliance Officer



Text Block




Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

SrItemCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.Web address
1Details of businessYeshttps://www.sonihospitals.com/about-soni-group/
2Terms and conditions of appointment of independent directorsYeswww.sonihospitals.com
3Composition of various committees of board of directorsYeshttps://www.sonihospitals.com/our-management/
4Code of conduct of board of directors and senior management personnelYeswww.sonihospitals.com
5Details of establishment of vigil mechanism/ Whistle Blower policyYeshttps://www.sonihospitals.com/wp-content/uploads/2018/03/VIGIL-MECHANISM_COMPLETE.pdf
6Criteria of making payments to non-executive directorsYeswww.sonihospitals.com
7Policy on dealing with related party transactionsYeshttps://www.sonihospitals.com/wp-content/uploads/2018/04/RPT_POLICY.pdf
8Policy for determining ‘material’ subsidiariesNA
9Details of familiarization programmes imparted to independent directorsNA

Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

SrItemCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.Web address
10Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievancesYeshttps://www.sonihospitals.com/corporate-information/
11email address for grievance redressal and other relevant detailsYeshttps://www.sonihospitals.com/corporate-information/
12Financial resultsYeshttps://www.sonihospitals.com/quarterly-financials/
13Shareholding patternYeshttps://www.sonihospitals.com/shareholding-pattern/
14Details of agreements entered into with the media companies and/or their associatesNA
15New name and the old name of the listed entityNA


Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
1Independent director(s) have been appointed in terms of specified criteria of ‘independence’ and/or ‘eligibility’16(1)(b) & 25(6)Yes
2Board composition17(1)Yes
3Meeting of Board of directors17(2)Yes
4Review of Compliance Reports17(3)Yes
5Plans for orderly succession for appointments17(4)Yes
6Code of Conduct17(5)Yes
7Fees/compensation17(6)Yes
8Minimum Information17(7)Yes
9Compliance Certificate17(8)Yes
10Risk Assessment & Management17(9)Yes

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
11Performance Evaluation of Independent Directors17(10)Yes
12Composition of Audit Committee18(1)Yes
13Meeting of Audit Committee18(2)Yes
14Composition of nomination & remuneration committee19(1) & (2)Yes
15Composition of Stakeholder Relationship Committee20(1) & (2)Yes
16Composition and role of risk management committee21(1),(2),(3),(4)NA
17Vigil Mechanism22Yes
18Policy for related party Transaction23(1),(5),(6),(7) & (8)Yes
19Prior or Omnibus approval of Audit Committee for all related party transactions23(2), (3)Yes
20Approval for material related party transactions23(4)Yes

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
21Composition of Board of Directors of unlisted material Subsidiary24(1)NA
22Other Corporate Governance requirements with respect to subsidiary of listed entity24(2),(3),(4),(5) & (6)NA
23Maximum Directorship & Tenure25(1) & (2)Yes
24Meeting of independent directors25(3) & (4)Yes
25Familiarization of independent directors25(7)NA
26Memberships in Committees26(1)Yes
27Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel26(3)Yes
28Disclosure of Shareholding by Non-Executive Directors26(4)Yes
29Policy with respect to Obligations of directors and senior management26(2) & 26(5)Yes
Any other information to be provided - Add Notes




Annexure II

1Name of signatoryPOOJA SHARMA
2DesignationCompany Secretary



Annexure II

III. Affirmations

SrParticularsCompliance status (Yes/No/NA)
1The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been compliedNA
Any other information to be provided




Annexure II

1Name of signatoryPOOJA SHARMA
2DesignationCompany Secretary



Signatory Details

Name of signatoryPOOJA SHARMA
Designation of personCompany Secretary
PlaceJAIPUR
Date13-04-2019